Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
Qi Shen1, Shuangwei Zou1, Bo Sheng1, Menghuang Zhao1, Lu-Zhe Sun2, Xueqiong Zhu1 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Cell Systems and Anatomy, University of Texas Health...
Main Authors: | Shen Q, Zou S, Sheng B, Zhao M, Sun LZ, Zhu X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mifepristone-inhibits-igf-1-signaling-pathway-in-the-treatment-of-uter-peer-reviewed-article-DDDT |
Similar Items
-
Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01) -
Mifepristone therapy in symptomatic leiomyomata using a variable dose pattern with a favourable outcome
by: Deepti Jain
Published: (2018-01-01) -
Torsion of a Uterine Leiomyoma
by: Yueh-Ju Tsai, et al.
Published: (2006-12-01) -
Uterine leiomyoma research
by: Tae Hee Kim, et al.
Published: (2015-06-01) -
POSSIBILITIES OF MIFEPRISTONE USE AFTER SURGICAL THERAPY OF UTERINE MYOMA
by: S. V. Apresyan, et al.
Published: (2016-12-01)